MedPath

Kalbrain

Brand Name: Kalbrain

Generic Name: Citicoline

Active
Registration Number

DR-XY49134

Dosage Form

Solution for Injection (IM/IV)

Issuance Date

August 1, 2024

Expiry Date

August 2, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength125 mg/mL
PackagingType I clear glass ampoule x 8 mL in 10 mL (Box of 5's in a blister plastic tray)

Classification

C
Classification
Prescription (Rx) Drug
P
Pharmacologic
Psychostimulant and nootropic.
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

CiticolineActive
Monograph: Citicoline

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform